ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
103 hedge funds and large institutions have $353M invested in Albireo Pharma Inc in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 33 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
29% less capital invested
Capital invested by funds: $495M → $353M (-$143M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
103
Holding in Top 10
2
Calls
$2.49M
Puts
$863K
Top Buyers
| 1 | +$10.2M | |
| 2 | +$7.84M | |
| 3 | +$6.74M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$4.61M |
| 5 |
JGC
J. Goldman & Co
New York
|
+$4.59M |
Top Sellers
| 1 | -$5.79M | |
| 2 | -$5.06M | |
| 3 | -$2.06M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.71M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.65M |